Clinical Trial Update: Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin plus gemcitabine with dexamethasone in patients with aggressive Non-Hodgkin lymphoma has completed. The snippet does not incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED